计算生物学
工作流程
优先次序
抗原
功能(生物学)
生物
计算机科学
受体酪氨酸激酶
图形
膜蛋白
图谱
维数(图论)
细胞
蛋白质-蛋白质相互作用
细胞生物学
班级(哲学)
细胞膜
交互网络
人细胞
血浆蛋白结合
相关
细胞功能
邻近效应(电子束光刻)
结合位点
作者
Cody Scandore,Clare F. Malone,Christopher K. May,Anna de Regt,Jeff Guernsey,Hayley Ma,Noah Dephoure,Ben Setter,Rebecca A. Howell,Kendall R. Johnson,Carol L. Farr,Sophia Romero,Lydia Vignale,Tali Vittum,Emma Dawson,Tsadik Ghebreamlak Habtetsion,Francesca Nardi,Brian Woodruff,Martin Mathay,Julia Swanson
出处
期刊:Nature
[Nature Portfolio]
日期:2026-09-09
卷期号:658 (8138): 1319-1329
被引量:2
标识
DOI:10.1038/s41586-026-11003-7
摘要
The spatial organization of membrane proteins is an underexplored dimension of cell surface biology1,2. Spatial proximity shapes cellular function and therapeutic targetability2,3, yet efforts to identify tumour-associated antigens (TAAs) have largely focused on expression alone4. Here, we developed an industrialized surface protein proximity-mapping workflow to interrogate TAAs within their membrane microenvironments. Using this workflow, we generated 248 proximity maps across 12 receptor tyrosine kinases and 28 tumour cell systems. The resulting atlas enabled the development of MetaMap, a correlation-based analytical framework that defines spatial protein communities and infers conserved proximity relationships among non-targeted proteins, and establishes the concept of tumour-associated proximity antigens (TAPAs), a class of co-targets defined by disease-specific spatial proximity to TAAs rather than expression alone. Integrating these proximity-derived relationships within a multimodal prioritization framework, we identified and validated EGFR–CDCP1 as a TAA–TAPA pair that enhances tumour cell killing across therapeutic modalities. Together, this work advances disease-associated membrane proximity as a guiding principle for the design of precision multispecific therapeutics. A proximity-mapping atlas defines tumour-associated proximity antigens, revealing disease-associated membrane spatial communities, and identifies EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI